ArticleArthritis & rheumatology (Hoboken, N.J.)2017

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.

Kevin L Winthrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.